- Home
- IFF vs DXCM Comparison
IFF vs DXCM Comparison
Compare IFF & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IFF
- DXCM
- Stock Information
- Founded
- IFF 1833
- DXCM 1999
- Country
- IFF United States
- DXCM United States
- Employees
- IFF N/A
- DXCM N/A
- Industry
- IFF Major Chemicals
- DXCM Medical/Dental Instruments
- Sector
- IFF Industrials
- DXCM Health Care
- Exchange
- IFF Nasdaq
- DXCM Nasdaq
- Market Cap
- IFF 19.6B
- DXCM 31.7B
- IPO Year
- IFF N/A
- DXCM 2005
- Fundamental
- Price
- IFF $64.85
- DXCM $76.26
- Analyst Decision
- IFF Strong Buy
- DXCM Strong Buy
- Analyst Count
- IFF 14
- DXCM 19
- Target Price
- IFF $92.25
- DXCM $99.89
- AVG Volume (30 Days)
- IFF 1.8M
- DXCM 4.1M
- Earning Date
- IFF 11-04-2025
- DXCM 10-23-2025
- Dividend Yield
- IFF 2.44%
- DXCM N/A
- EPS Growth
- IFF N/A
- DXCM N/A
- EPS
- IFF N/A
- DXCM 1.43
- Revenue
- IFF $11,303,000,000.00
- DXCM $4,300,800,000.00
- Revenue This Year
- IFF N/A
- DXCM $17.03
- Revenue Next Year
- IFF N/A
- DXCM $15.59
- P/E Ratio
- IFF N/A
- DXCM $53.30
- Revenue Growth
- IFF N/A
- DXCM 9.30
- 52 Week Low
- IFF $62.33
- DXCM $57.52
- 52 Week High
- IFF $106.77
- DXCM $93.25
- Technical
- Relative Strength Index (RSI)
- IFF 40.53
- DXCM 44.22
- Support Level
- IFF $63.97
- DXCM $75.39
- Resistance Level
- IFF $66.54
- DXCM $81.64
- Average True Range (ATR)
- IFF 1.29
- DXCM 2.23
- MACD
- IFF 0.15
- DXCM 0.02
- Stochastic Oscillator
- IFF 27.37
- DXCM 39.18
About IFF International Flavors & Fragrances Inc.
International Flavors & Fragrances is the largest specialty ingredients producer globally. It sells ingredients for the food, beverage, health, household goods, personal care, and pharmaceutical industries. The company makes proprietary formulations, partnering with customers to deliver custom solutions. Through its taste and scent segments, which each generate around 25% of profits, IFF is a leading flavor and fragrances producer. The health and biosciences business, which generates 30% of profits, is a global leader in probiotics and enzymes. The remaining profits come from the food ingredients business, which sells texturants, plant-based proteins, and other ingredients.
About DXCM DexCom Inc.
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.